NanoViricides Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2006
Net Income	-8.59	-8.11	-8.82	-13.45	-8.42	-8.56	-10.3	-10.72	-2.2	-13.6	Upgrade
Depreciation & Amortization	0.75	0.72	0.7	0.7	0.7	0.68	0.66	0.66	0.3	0.21	Upgrade
Share-Based Compensation	0	0	0	0	0.01	0	0	0	0	0	Upgrade
Other Operating Activities	2.17	1.49	-0.1	6.08	0.91	0.11	1.74	3.24	-4.32	7.06	Upgrade
Operating Cash Flow	-5.67	-5.89	-8.21	-6.67	-6.8	-7.78	-7.9	-6.83	-6.21	-6.33	Upgrade
Capital Expenditures	-0.15	-0.32	-0.24	-0.01	-0.07	-0.24	-0.16	-0.48	-6.76	-5.23	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	-	1	-	Upgrade
Investing Cash Flow	-0.15	-0.32	-0.24	-0.01	-0.07	-0.24	-0.16	-0.48	-5.76	-5.23	Upgrade
Share Issuance / Repurchase	0	0	16.56	16.68	2.35	0	0	0	6.74	29.34	Upgrade
Debt Issued / Paid	-0.09	-0.23	-1.3	1.16	0	0	-1	0	0	5	Upgrade
Other Financing Activities	-	-	-	-0.01	-	-	-	-	-	-	Upgrade
Financing Cash Flow	-0.09	-0.23	15.26	17.83	2.35	0	-1	0	6.74	34.34	Upgrade
Net Cash Flow	-5.92	-6.45	6.81	11.15	-4.53	-8.02	-9.06	-7.31	-5.23	22.77	Upgrade
Free Cash Flow	-5.82	-6.22	-8.45	-6.67	-6.88	-8.02	-8.06	-7.31	-12.97	-11.56	Upgrade
Free Cash Flow Per Share	-0.50	-0.54	-0.78	-1.19	-1.92	-2.47	-2.68	-2.53	-4.59	-4.51	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).